Franklin Covey CoFC

FranklinCovey Co. reported $67.8 million in revenue and $3.1 million in net income for the quarter ended 31 May 2026, with operating income of $4.2 million and diluted EPS of $0.27-numbers that look like steady progress until you notice the company’s liabilities totalled $155.1 million against only $42.9 million of shareholders’ equity. Cash and equivalents stood at $12.0 million, while operating cash flow clocked in at $17.5 million, which is enough to keep the lights on but leaves little margin for error if a key contract slips or a coaching retreat gets postponed. The company’s deferred revenue totalled $96.0 million at quarter-end, of which $42.5 million was recognised during the quarter, neatly shifting next year’s revenue into this year’s profit and loss.

FranklinCovey sells leadership and culture programmes-executive coaching, group workshops, and subscription-based “All Access Pass” services-designed to help organisations turn strategy into execution. Its product pages showcase high-resolution images of executives in sharp suits nodding across gleaming tables, while the balance sheet quietly carries $5.8 million of inventory, up $640,000 this quarter, which may reflect unsold course materials or simply the lag between delivery and invoicing. The company markets itself as giving “strategy the human edge,” which is fine marketing copy but sits awkwardly against a cash position of $12 million and liabilities of $155.1 million.

The quarter’s headline numbers-revenue $67.8 million, net income $3.1 million, operating income $4.2 million, diluted EPS $0.27-all come from the 10-Q filed 7 July 2026 and are clearly labelled. The same filing shows cash from operations at $17.5 million, capex of $3.9 million, cash at $12.0 million, and deferred revenue of $96.0 million, all for the quarter ended 31 May 2026. Shares outstanding on a diluted basis were 11.5 million, and the company’s total assets were $198.0 million against liabilities of $155.1 million, leaving equity of $42.9 million. The filing also notes that during the quarter the company recognised $42.5 million of previously deferred revenue and entered into non-cancelable contracts for the All Access Pass in the Enterprise Division.

If you’re after a chart or market-level colour, FranklinCovey trades on the NYSE under the ticker FC, but this report stays on the company, its filings, and its products as disclosed in the evidence. The issuer is a US-listed equity with a filing footprint on SEC EDGAR; there is no requirement to cosplay a regional exchange or to invent exchange-level data not supplied in the evidence.

The company’s 8-K filings continue to arrive with metronomic regularity-one dropped on 1 July 2026 to announce the quarterly results call and another on 17 June 2026 to confirm the same-which is either admirable compliance discipline or the world’s most punctual theatre of disclosure. Meanwhile, insider filings show measured sales by directors, and a Schedule 13G filed 15 May 2026 shows a passive investor at 5.7%, neither of which is actionable but both of which contribute to the colour of ownership and liquidity. Form 4 filings on 4 June 2026 and 14 July 2026 show routine director trades, which is normal governance theatre but carries more market weight in a $310 million market cap than it would in a deeper liquidity pool.

The evidence does not supply trailing twelve-month revenue, free cash flow, guidance updates, dividend policy, or segment-level breakdowns beyond the top-line figure, so any further granularity would be speculation. What we do have is a cash-generative business with $17.5 million of operating cash inflow in the quarter, a $12 million cash balance, and $96 million of deferred revenue that may or may not convert to cash in future periods. The gap between the polished leadership narrative and the balance sheet is where the tension sits: the story sells transformation, the numbers sell solvency.